A CLINICAL PRACTICE GUIDELINE DEVELOPED BY CANCER AUSTRALIA
This guideline was first published in November 2011 and has been updated to incorporate new evidence.
This guideline includes statements, recommendations and practice points based on available, high-level evidence about the use of hypofractionated radiotherapy for the treatment of women with early (operable) breast cancer. The guideline aims to provide all health professionals within a multi-disciplinary team with information to assist in making management recommendations for improved patient outcomes.
This resource has been developed, reviewed or revised within the last 5 years.